8-K filing — enGene Therapeutics Inc. (ENGNW)
Filed: 2026-09-08 AccNo: 0001193125-26-384380 Size: 419 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Stocks · News reference
8-K/A filing — enGene Therapeutics Inc. (ENGNW)
Filed: 2026-06-18 AccNo: 0001193125-26-275815 Size: 202 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading